Insulin Therapy in Type-II Diabetes Mellitus – Is it Feasible and Acceptable?

Published on:June 2019
Indian Journal of Pharmacy Practice, 2019; 12(2):77-83
Research Article | doi:10.5530/ijopp.12.2.19

Insulin Therapy in Type-II Diabetes Mellitus – Is it Feasible and Acceptable?

Authors and affiliation (s):

Aditya Mundra1,*, Dimple Jain1, Vikas Raman Chandrakar1, Jitendra Dewji Lakhani2

1Department of Pharmacy, Sumandeep Vidyapeeth Deemed University, Vadodara, Gujarat, INDIA.

2Smt. B.K. Shah (SBKS) Medical Institute and Research Center, Sumandeep Vidyapeeth (Deemed University), Vadodara, Gujarat, INDIA.


Background: Insulin, being the mainstay of treatment for type1 and certain situations in type 2 Diabetes mellitus (DM), is still not properly utilized. Thus, this study was done to know the barriers that lead to suboptimal utilization of insulin therapy by stakeholders particularly in our group of patients who were mostly from rural background. Methods: An observational, cross-sectional study with sample size of 100 patients with Type 2 DM that were prescribed with insulin or were already on insulin was done. Patient were interviewed on basis of pre-structured socio-demographic, knowledge, attitude and practice questionnaire and accordingly counseled. Data was analyzed by percentages and student’s t-test. Results: Around 58% patients, in whom insulin was indicated, were taking insulin therapy. Limited knowledge about the disease and insulin, in addition to wrongful attitude and practices were barriers to therapy. Less than 50% patients had proper knowledge and understanding about insulin therapy. They had misconception of “habit” forming character of insulin and of hypoglycemia. Social stigma, inconvenience, life-long therapy commitment, cost, phobias were other causes for resistance to the use of insulin. Conclusion: This study concludes that by understanding patient’s attitude towards insulin therapy healthcare professionals can aim to modify their misconceptions. Difference can be made by educating patients through proper counseling by clinical pharmacist in harmony with other healthcare professionals. This will not only help in delivering proper patient-centered care but will also help in improving the way patient looks at diabetes and insulin, thus revolutionizing the diabetic world.

Key words: Clinical Pharmacist, Type2DM, Insulin Therapy, KAP Survey, KAP Questionnaire.


The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmacy Practice (IJOPP) [ISSN-0974-8326] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 2008.


IJOPP uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2014 are being assigned DOIs for its permanent URLs